Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 3/20 | 0.44 |
| ▸ | FUCA1 | P04066 | 3/20 | 0.44 |
| ▸ | GLA | P06280 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | GLB1 | P16278 | 1/20 | 0.35 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | NGLY1 | Q96IV0 | 1/20 | 0.35 |
| ▸ | GANAB | Q14697 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14351162 | 1.00 | GBA1 (0.44) | GBA1GAAFUCA1GLALMNA | |
| SCHEMBL12871337 | 1.00 | GBA1 (0.44) | GBA1GAAFUCA1GLALMNA | |
| SCHEMBL14039702 | 1.00 | GBA1 (0.44) | GBA1GAAFUCA1GLALMNA | |
| SCHEMBL11982840 | 0.95 | LMNA (0.46) | GBA1GAAFUCA1GLALMNA | |
| SCHEMBL15484135 | 0.95 | LMNA (0.46) | GBA1GAAFUCA1GLALMNA | |
| SCHEMBL15484220 | 0.95 | LMNA (0.46) | GBA1GAAFUCA1GLALMNA | |
| Methyl Alcohol SCHEMBL11572710 | 0.91 | FUCA1 (0.39) | GBA1GAAFUCA1GLAGBA2 | |
| SCHEMBL1964660 | 0.90 | — | — | |
| SCHEMBL16843045 | 0.90 | — | — | |
| SCHEMBL18387079 | 0.90 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250250414-A1 | STABILISED, TRANSITION-METAL-CONTAINING PLASTICS COMPOSITIONS, MOULDING COMPOUND OR MOULDED PART AND USE OF A STABILISER COMPOSITION FOR STABILISING TRANSITION METAL-CONTAINING PLASTICS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-08-07 | — | — | US | claimed |
| EP-4508127-A1 | STABILISED, TRANSITION-METAL-CONTAINING PLASTICS COMPOSITIONS, MOULDING COMPOUND OR MOULDED PART AND USE OF A STABILISER COMPOSITION FOR STABILISING TRANSITION-METAL-CONTAINING PLASTICS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-02-19 | — | — | EP | claimed |
| CN-119213079-A | Stabilized transition metal-containing plastic compositions, molding compounds or molded parts, and use of stabilizer compositions for stabilizing transition metal-containing plastics | 弗劳恩霍夫应用研究促进协会 | 2024-12-27 | — | — | CN | claimed |
| WO-2023198777-A1 | STABILISED, TRANSITION-METAL-CONTAINING PLASTICS COMPOSITIONS, MOULDING COMPOUND OR MOULDED PART AND USE OF A STABILISER COMPOSITION FOR STABILISING TRANSITION-METAL-CONTAINING PLASTICS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2023-10-19 | — | — | WO | claimed |
| US-20200236932-A1 | POLYALCOHOL, CARBOHYDRATE, NUCLEOBASE AND NUCLEOTIDE COMPOSITIONS AND USES THEREOF | ZHANG, CHUNBO | 2020-07-30 | — | — | US | claimed |
| WO-2017053467-A1 | POLYALCOHOL, CARBOHYDRATE, NUCLEOBASE AND NUCLEOSIDE COMPOSITIONS AND USES THEREOF | COMBI-BLOCKS, INC. (US) | 2017-03-30 | — | — | WO | claimed |
| CN-104610222-A | Process for preparing episulfide compounds | ASAHI KASEI CHEMICALS CORP | 2015-05-13 | — | — | CN | claimed |
| EP-0957903-A4 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS INC (US) | 2002-10-09 | — | — | EP | claimed |
| EP-0957903-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | Codon Pharmaceuticals, Inc. (US) | 1999-11-24 | — | — | EP | claimed |
| WO-1998011882-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS | CODON PHARMACEUTICALS, INC. (US) | 1998-03-26 | — | — | WO | claimed |
| US-12552913-B2 | Use of phenolically substituted sugar derivatives as stabilisers, plastic composition, method for stabilising plastics and phenolically substituted sugar derivatives | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2026-02-17 | — | — | US | disclosed |
| US-20250250414-A1 | STABILISED, TRANSITION-METAL-CONTAINING PLASTICS COMPOSITIONS, MOULDING COMPOUND OR MOULDED PART AND USE OF A STABILISER COMPOSITION FOR STABILISING TRANSITION METAL-CONTAINING PLASTICS | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-08-07 | — | — | US | disclosed |
| EP-4293072-B1 | MECHANOCHEMICAL PROCESS FOR THE PRODUCTION VALUABLES FREE OF PERSISTENT ORGANIC POLLUTANTS AND OTHER ORGANOHALOGEN COMPOUNDS FROM WASTE OF PLASTICS AND PLASTIC LAMINATES | SMART MAT PRINTING B V (NL) | 2025-07-23 | — | — | EP | disclosed |
| EP-4543975-A1 | STABILISER COMPOSITION, USE OF THE STABILISER COMPOSITION, METHOD FOR STABILISING CONDENSATION POLYMERS AGAINST HYDROLYTIC DEGRADATION, AND HYDROLYSIS-STABILISED COMPOSITION AND MOULDING OR MOULDED PART CONSISTING THEREOF | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-04-30 | — | — | EP | disclosed |
| US-20250122357-A1 | STABILIZERS BASED ON SYRINGIC ACID, VANILLIC ACID, ISOVANILLIC ACID OR 5-HYDROXYVERATRIC ACID, PLASTIC COMPOSITION, METHOD FOR STABILIZING A PLASTIC COMPOSITION AND STABILIZER COMPOSITION | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2025-04-17 | — | — | US | disclosed |
| US-5072794-A | Circulating water-free drilling fluid containing polyol or cyclic ether polyol | SHELL OIL COMPANY (US) | 1991-12-17 | — | — | US | disclosed |
| US-5058679-A | Adding blast furnace slag | SHELL OIL COMPANY (US) | 1991-10-22 | — | — | US | disclosed |
| US-5020598-A | Injecting mixture of polyalcohols and cement to make fluid-tight sealing | SHELL OIL COMPANY (US) | 1991-06-04 | — | — | US | disclosed |
| US-4898986-A | Inosose derivatives, production and use thereof | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-02-06 | — | — | US | disclosed |
| EP-0260121-A2 | Inosose derivatives, production and use thereof | Takeda Chemical Industries, Ltd. (JP) | 1988-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200236932-A1 | POLYALCOHOL, CARBOHYDRATE, NUCLEOBASE AND NUCLEOTIDE COMPOSITIONS AND USES THEREOF | PNP, RNMT, RNGTT | GBA1 566/4885GAA 573/4885FUCA1 1165/4885 |
| US-12552913-B2 | Use of phenolically substituted sugar derivatives as stabilisers, plastic composition, method for stabilising plastics and phenolically substituted sugar derivatives | SORD, GYS1, GYS2 | GBA1 641/4885GAA 744/4885FUCA1 366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.